Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

GT Biopharma (GTBP) Return on Assets (2016 - 2021)

GT Biopharma (GTBP) has disclosed Return on Assets for 10 consecutive years, with 0.66% as the latest value for Q3 2021.

  • On a quarterly basis, Return on Assets rose 1433.0% to 0.66% in Q3 2021 year-over-year; TTM through Sep 2021 was 0.66%, a 1433.0% increase, with the full-year FY2020 number at 2.17%, changed N/A from a year prior.
  • Return on Assets was 0.66% for Q3 2021 at GT Biopharma, down from 0.65% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.57% in Q4 2020 to a low of 180.32% in Q2 2017.
  • A 5-year average of 36.55% and a median of 5.84% in 2018 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: tumbled -46347bps in 2017, then skyrocketed 17971bps in 2018.
  • GT Biopharma's Return on Assets stood at 0.56% in 2017, then tumbled by -227bps to 1.84% in 2018, then tumbled by -4675bps to 88.03% in 2019, then soared by 101bps to 0.57% in 2020, then crashed by -216bps to 0.66% in 2021.
  • Per Business Quant, the three most recent readings for GTBP's Return on Assets are 0.66% (Q3 2021), 0.65% (Q2 2021), and 1.57% (Q1 2021).